Repression of NF-kappaB Impairs HeLa Cell Proliferation by Functional Interference with Cell Cycle Checkpoint Regulators
Overview
Affiliations
NF-kappaB is an inducible transcription factor, which is regulated by interaction with inhibitory IkappaB proteins. Previous studies linked the activity of NF-kappaB to the proliferative state of the cell. Here we have analysed the function of NF-kappaB in the cell cycle. Inhibition of NF-kappaB in HeLa cells by stable overexpression of a transdominant negative IkappaB-alpha protein reduced cell growth. A kinetic analysis of the cell cycle revealed a retarded G1/S transition. The IkappaB-alpha overexpressing cell clones showed a decreased percentage of cells in the S phase and an impaired incorporation of bromodeoxyuridine (BrdU). The amounts of cyclins A, B1, D1, D3, and E were unchanged, but the G1-specific proteins cyclin D2 and cdk2 were strongly elevated in the IkappaB-alpha overexpressing cell clones. These cell clones also displayed an increase in cyclin D1-dependent kinase activity, pointing to a cell cycle arrest at the late G1 phase. IkappaB-alpha overexpression crosstalked to cell cycle checkpoints via a reduction of transcription factor p53 and elevation of p21WAF. Surprisingly, the IkappaB-alpha overexpressing cells showed an enrichment of c-Myc in the nucleoli, although the total amount of c-Myc protein was unchanged. These experiments identify an important contribution of the NF-kappaB/IkappaB system for the growth of HeLa cells.
PRMT5 is a therapeutic target in choroidal neovascularization.
Muniyandi A, Martin M, Sishtla K, Motolani A, Sun M, Jensen N Sci Rep. 2023; 13(1):1747.
PMID: 36720900 PMC: 9889383. DOI: 10.1038/s41598-023-28215-w.
The NF-κB pathway is critically implicated in the oncogenic phenotype of human osteosarcoma cells.
Tan B, Yuan Z, Zhang Q, Xiqiang X, Dong J J Appl Biomed. 2021; 19(4):190-201.
PMID: 34907738 DOI: 10.32725/jab.2021.021.
PLEKHG5 regulates autophagy, survival and MGMT expression in U251-MG glioblastoma cells.
Witte K, Slotta C, Lutkemeyer M, Kitke A, Coras R, Simon M Sci Rep. 2020; 10(1):21858.
PMID: 33318498 PMC: 7736842. DOI: 10.1038/s41598-020-77958-3.
Lu C, Lin C, Chang Y, Chen H, Chung W, Lai W J Immunother Cancer. 2020; 8(2).
PMID: 33243934 PMC: 7692992. DOI: 10.1136/jitc-2020-001392.
Noel J, Suzukawa K, Chavez E, Pak K, Wasserman S, Kurabi A PLoS One. 2020; 15(8):e0235634.
PMID: 32760078 PMC: 7410257. DOI: 10.1371/journal.pone.0235634.